Legislation

Now that there is a Speaker of the US House, there is an opportunity to advance the reauthorization of the SUPPORT Act in both chambers. However, without a major push by stakeholders, its advancement is in jeopardy. Thus, no later than 5pm ET, Wednesday, November 1, please consider adding your organization’s name to a brief letter, drafted by ASAM and the Overdose Prevention...

FOR IMMEDIATE RELEASE July 19, 2023 (Download here) Key Addiction Provisions Included in the SUPPORT for Patients and Communities Reauthorization Act will Bolster the Addiction Care Workforce and Expand Access to Addiction Medicine Rockville, MD – Today, the American Society of Addiction Medicine (ASAM) applauded the House Energy & Commerce Committee for voting to include key...

Synopsis: The importance of responsibly expanding access to methadone treatment for opioid use disorder (OUD) is crucial. Methadone, a long-lasting opioid agonist, is a well-studied and effective medical treatment for OUD, which is associated with a significantly higher risk of early death. While there is support for liberalizing access to methadone from opioid treatment programs...

On May 10th, national organizations, including the American Society of Addiction Medicine, the American College of Emergency Physicians, the American Psychological Association, the American Psychiatric Association, and Faces & Voices of Recovery, held a briefing for the 118th Congress, and strongly encouraged a national response to the deadly substance use and addiction crisis...

Today, the Centers for Medicare & Medicaid Services (CMS) issued a letter to State Medicaid Directors announcing a new opportunity for states to help increase care for individuals who are incarcerated in the period immediately prior to their release. The new Medicaid Reentry Section 1115 Demonstration Opportunity will allow state Medicaid programs to cover a package of pre-release...

Hi Chapter Presidents – Hope all is well. US Senators Markey and Paul (as well as their House counterparts) plan to introduce – soon – the portions of the Opioid Treatment Access Act (OTAA) from the last Congress that didn’t make it into the Consolidated Appropriations Act, 2023. Attached is that draft legislation. In brief, this legislation, now named the “Modernizing Opioid...

Good Morning, ASAM Chapter Presidents and Advocacy Leaders: SAMHSA has recently posted the following message on its website: Congress has taken action in the recent Consolidated Appropriations Act, 2023 that impacts federal requirements for Drug Enforcement Administration (DEA) registrants, including those involved in OUD treatment. SAMHSA and DEA are actively working to develop further...

Section 1262 of the Consolidated Appropriations Act, 2023 (also known as Omnibus bill), removes the federal requirement for practitioners to submit a Notice of Intent (have a waiver) to prescribe medications, like buprenorphine, for the treatment of opioid use disorder (OUD). With this provision, and effective immediately, SAMHSA will no longer be accepting NOIs (waiver applications). All...

Dear Registrants: On December 29, 2022, with the signing of the Consolidated Appropriations Act of 2023 (the Act), Congress eliminated the “DATA Waiver Program.” DEA fully supports this significant policy reform. ln this moment, when the United States is suffering tens of thousands of opioid-related drug poisoning deaths every year, the DEA’s top priority is doing...

Good Evening – I bring good news. One thing ASAM was not able to achieve – which had been on our legislative agenda – during our Addiction Medicine Advocacy Conference last year – was the passage of the Medicaid Reentry Act, which would have allowed for Medicaid coverage for eligible individuals – who were incarcerated – up to 30 days prior to their release....

Sign-On Opportunity: 5pm ET, November 1 Deadline: Stakeholder Letter Calling for the Reauthorization of the SUPPORT Act

ASAM Applauds House Energy & Commerce Committee for Advancing Key Addiction Provisions in Bipartisan Legislation

The Modernizing Opioid Treatment Access Act: A Helpful Explanation

Congressional Briefing, Expert Panel Suggests Innovative Solutions to National Addiction Crisis

CMS Issues Letter to State Medicaid Directors to Improve Care Transitions for Incarcerated Individuals

Legislative Draft for the Consolidated Appropriations Act, 2023

Congress Takes Action Which Impacts Federal Requirements for DEA Registrants

NEW SAMHSA MESSAGE ON CONSOLIDATED APPROPRIATIONS ACT, 2023

Bye-bye X-Waiver

Critical Pre-release Services for Incarcerated Individuals

The Georgia Society of Addiction Medicine